FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/09/2023
Voltar para busca
Dado oficial do USPTO
LIGHTBULB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
12/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
22/09/2021
Data de registro
16/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/05/2023
Última transação
08/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
CAPSHAW, DANIEL
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Touchlight IP Limited
Representantes
Rebecca Liebowitz Venable LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparationsenzymes and DNA for the preparation of nucleic acid for scientific researchnamely nucleic acid constructs; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnologynamely nucleic acid constructs other than for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for use in nanotechnology applications including data storagedata retrieval and computingnamely nucleic acid constructs other than for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for use in nanotechnology applications including data storagedata retrieval and computing other than for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for use in nanotechnology applications including data storagedata retrieval and computingnamely nucleic acid constructs other than for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for laboratory use in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for laboratory use in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for laboratory use in creating nanostructures and scaffolds; nucleic acids and nucleic acid analogues for labellingimaging and sensing applications for scientific and research purposes; nucleic acids and nucleic acid analogues as smart materials for scientific and research purposes; two-dimensional and three-dimensional nucleic acids and nucleic acid analogues for creating nanostructures and scaffolds for scientific and research purposes; parts and fittings for all the aforesaid technology; all the aforesaid goods for use in nanotechnology applications including data storagedata retrieval and computing
Classe 5
Vaccines; DNA based vaccines; DNA extractsnucleic acid sequences and chemical reagents for medical use; therapeutic DNAnucleic acid sequences and chemical reagents for medical and veterinary purposes; nucleic acids comprising natural and unnatural nucleotides for medical and veterinary purposes; nucleic acid analogues comprising synthetic backbones or a mixture of natural and synthetic backbones for medical and veterinary purposes; composites of nucleic acids or nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in labellingimaging and sensing applications; nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in smart materials; two-dimensional and three-dimensional nucleic acid analogues with organic and inorganic chemicals for medical and veterinary purposes in creating nanostructures and scaffolds
Classe 9
Electronic componentsnano-wiressemi-conductorstransistorsrectifiersdiodesbatteries all the aforesaid goods being manufactured from or including nucleic acidsnucleic acid constructs and nucleic acid analogues; structural parts and fittings for all the aforesaid goods
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/08/2023
FIMP
FINAL DISPOSITION PROCESSED
19/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/08/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
16/05/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2023
PUBO
PUBLISHED FOR OPPOSITION
28/02/2023
GPNX
NOTIFICATION PROCESSED BY IB
27/02/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/02/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/02/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/12/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2022
RFNT
REFUSAL PROCESSED BY IB
20/07/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/06/2022
RFRR
REFUSAL PROCESSED BY MPU
28/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/06/2022
CNRT
NON-FINAL ACTION WRITTEN
10/06/2022
DOCK
ASSIGNED TO EXAMINER
07/06/2022
MAFR
APPLICATION FILING RECEIPT MAILED
26/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/02/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
17/02/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIGHTBULB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.